CompanyPrivateBoston, MA

Scorpion Therapeutics, Inc

SEC EDGAR ClinicalTrials.gov

10-QOct 29Latest SEC filing

Form DJul 16$126M sold

November 2026

Lilly posts Phase 2b retatrutide renal results; registers tersolisib kidney PK study

Nov 9Weekly roundup, 2 itemsEli Lilly retatrutide